ArticleNature genetics2019
Author Correction: Atlas of group A streptococcal vaccine candidates compiled using large-scale comparative genomics.
Abstract readPublished Erratum
In one paragraph
Article in Nature genetics, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Research opportunities for the primordial prevention of rheumatic fever and rheumatic heart disease-streptococcal vaccine development: a national heart, lung and blood institute workshop report.BMJ global health · 2023Review
- A brief review on Group A Streptococcus pathogenesis and vaccine development.Royal Society open science · 2021Review
- Article
Corrections and comments
- Erratum for
Authors and funding
38 authors.
Mark R DaviesDepartment of Microbiology and Immunology, The Peter Doherty Institute for Infection and Immunity, The University of Melbourne and The Royal Melbourne Hospital, Melbourne, Victoria, Australia. mark.davies1@unimelb.edu.au.ORCID http://orcid.org/0000-0001-6141-5179
Liam McIntyreDepartment of Microbiology and Immunology, The Peter Doherty Institute for Infection and Immunity, The University of Melbourne and The Royal Melbourne Hospital, Melbourne, Victoria, Australia.
Ankur MutrejaThe Wellcome Trust Sanger Institute, Hinxton, UK.
Jake A LaceyDoherty Department, The Peter Doherty Institute for Infection and Immunity, The University of Melbourne and The Royal Melbourne Hospital, Melbourne, Victoria, Australia.
John A LeesDepartment of Microbiology, New York University School of Medicine, New York, NY, USA.
Rebecca J TowersMenzies School of Health Research, Darwin, Northern Territory, Australia.
Sebastián DuchêneDepartment of Microbiology and Immunology, The Peter Doherty Institute for Infection and Immunity, The University of Melbourne and The Royal Melbourne Hospital, Melbourne, Victoria, Australia.
Pierre R SmeestersMolecular Bacteriology Laboratory, Université Libre de Bruxelles, Brussels, Belgium.
Hannah R FrostMolecular Bacteriology Laboratory, Université Libre de Bruxelles, Brussels, Belgium.ORCID http://orcid.org/0000-0002-1543-2805
David J PriceCentre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Melbourne, Victoria, Australia.ORCID http://orcid.org/0000-0003-0076-3123
Matthew T G HoldenThe Wellcome Trust Sanger Institute, Hinxton, UK.ORCID http://orcid.org/0000-0002-4958-2166
Sophia DavidThe Wellcome Trust Sanger Institute, Hinxton, UK.
Philip M GiffardMenzies School of Health Research, Darwin, Northern Territory, Australia.
Kate A WorthingDepartment of Microbiology and Immunology, The Peter Doherty Institute for Infection and Immunity, The University of Melbourne and The Royal Melbourne Hospital, Melbourne, Victoria, Australia.
Anna C SealeWellcome Trust Research Centre, Kilifi, Kenya.
James A BerkleyCentre for Tropical Medicine and Global Health, Nuffield Department of Medicine, University of Oxford, Oxford, UK.ORCID http://orcid.org/0000-0002-1236-849X
Simon R HarrisThe Wellcome Trust Sanger Institute, Hinxton, UK.
Tania Rivera-HernandezSchool of Chemistry and Molecular Biosciences, The University of Queensland, Brisbane, Queensland, Australia.
Olga BerkingSchool of Chemistry and Molecular Biosciences, The University of Queensland, Brisbane, Queensland, Australia.
Amanda J CorkSchool of Chemistry and Molecular Biosciences, The University of Queensland, Brisbane, Queensland, Australia.
Rosângela S L A TorresLaboratory of Bacteriology, Epidemiology Laboratory and Disease Control Division, Laboratório Central do Estado do Paraná, Curitiba, Brazil.
Trevor LithgowInfection and Immunity Program, Biomedicine Discovery Institute and Department of Microbiology, Monash University, Melbourne, Victoria, Australia.
Richard A StrugnellDepartment of Microbiology and Immunology, The Peter Doherty Institute for Infection and Immunity, The University of Melbourne and The Royal Melbourne Hospital, Melbourne, Victoria, Australia.ORCID http://orcid.org/0000-0003-0614-5641
Rene BergmannHelmholtz Centre for Infection Research, Braunschweig, Germany.
Patric Nitsche-SchmitzHelmholtz Centre for Infection Research, Braunschweig, Germany.
Gusharan S ChhatwalHelmholtz Centre for Infection Research, Braunschweig, Germany.
Stephen D BentleyThe Wellcome Trust Sanger Institute, Hinxton, UK.
John D FraserFaculty of Medical and Health Sciences, University of Auckland, Auckland, New Zealand.
Nicole J MorelandFaculty of Medical and Health Sciences, University of Auckland, Auckland, New Zealand.
Jonathan R CarapetisTelethon Kids Institute, University of Western Australia and Perth Children's Hospital, Perth, Western Australia, Australia.
Andrew C SteerMurdoch Childrens Research Institute, Melbourne, Victoria, Australia.
Julian ParkhillThe Wellcome Trust Sanger Institute, Hinxton, UK.ORCID http://orcid.org/0000-0002-7069-5958
Allan SaulGSK Vaccines Institute for Global Health, Siena, Italy.
Deborah A WilliamsonMicrobiological Diagnostic Unit Public Health Laboratory, Department of Microbiology and Immunology, The Peter Doherty Institute for Infection and Immunity, The University of Melbourne and The Royal Melbourne Hospital, Melbourne, Victoria, Australia.
Bart J CurrieMenzies School of Health Research, Darwin, Northern Territory, Australia.
Steven Y C TongDoherty Department, The Peter Doherty Institute for Infection and Immunity, The University of Melbourne and The Royal Melbourne Hospital, Melbourne, Victoria, Australia.
Gordon DouganThe Wellcome Trust Sanger Institute, Hinxton, UK.
Mark J WalkerSchool of Chemistry and Molecular Biosciences, The University of Queensland, Brisbane, Queensland, Australia. mark.walker@uq.edu.au.ORCID http://orcid.org/0000-0001-7423-2769
Funding
No grant is acknowledged in the PubMed record.
Abstract
An amendment to this paper has been published and can be accessed via a link at the top of the paper.
Identifiers
PMID
31324894What OpenQuestion holds
Textmetadata
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.